2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Author(s)
Type
Journal Article
Date Issued
2016-08-27
Date Acceptance
2016-08-01
Citation
European Journal of Heart Failure, 2016, 19 (1), pp.9-42
ISSN
1879-0844
Publisher
Wiley
Start Page
9
End Page
42
Journal / Book Title
European Journal of Heart Failure
Volume
19
Issue
1
Sponsor
British Heart Foundation
Action Against Cancer
Grant Number
FS/11/67/28954
042016-05
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
European Society of Cardiology
chemotherapy
cardiotoxicity
cardio-oncology
myocardial dysfunction
arrhythmias
ischaemia
early detection
surveillance
cancer therapy
HER2-POSITIVE BREAST-CANCER
CONGESTIVE-HEART-FAILURE
ANTHRACYCLINE-INDUCED CARDIOMYOPATHY
LEFT-VENTRICULAR DYSFUNCTION
CORONARY-ARTERY-DISEASE
RENAL-CELL CARCINOMA
ACUTE LYMPHOBLASTIC-LEUKEMIA
TYROSINE KINASE INHIBITORS
CHEMOTHERAPY-INDUCED CARDIOTOXICITY
TRASTUZUMAB-INDUCED CARDIOTOXICITY
Authors/Task Force Members
ESC Committee for Practice Guidelines (CPG)
Document Reviewers
1102 Cardiovascular Medicine And Haematology
Cardiovascular System & Hematology
Publication Status
Published